ONCOLOGY

A New Mode of Cytotoxic T Lymphocyte Induction Secondary to Alteration of the Peptide/Major Histocompatibility Complex Class I Repertoire by Antigen Processing Defects

Dec 10, 2016 by in ONCOLOGY Comments Off on A New Mode of Cytotoxic T Lymphocyte Induction Secondary to Alteration of the Peptide/Major Histocompatibility Complex Class I Repertoire by Antigen Processing Defects

Fig. 16.1 The altered peptide/major histocompatibility complex class I (pMHCI) repertoire caused by antigen-processing defect (APD). In ERAAP-deficient or tapasin-deficient cells, the total amount of pMHCI on the cell surface…

read more

The Role of PIKfyve in Toll-Like Receptor-Mediated Responses

Dec 10, 2016 by in ONCOLOGY Comments Off on The Role of PIKfyve in Toll-Like Receptor-Mediated Responses

Diseases Number of patients Results Effect of apilimod on cytokine production Ref. Crohn’s disease 73 Significant  Burakoff et al. (2006) Crohn’s disease  Significant  Billich (2007) Crohn’s disease 220 Not significant …

read more

In Vivo Targeting of Dendritic Cells with Artificial Adjuvant Vector Cells (aAVC) as a Novel Cancer Immunotherapy

Dec 10, 2016 by in ONCOLOGY Comments Off on In Vivo Targeting of Dendritic Cells with Artificial Adjuvant Vector Cells (aAVC) as a Novel Cancer Immunotherapy

Fig. 13.1 Invariant natural killer T (iNKT) cell-mediated adjuvant effects on T cells are dependent on the innate immunity. Intravenously administered artificial adjuvant vector cells (aAVCs) are killed by iNKT…

read more

Innate Immune Receptor Signaling and IRF Family of Transcription Factors: Good Deeds and Misdeeds in Oncogenesis

Dec 10, 2016 by in ONCOLOGY Comments Off on Innate Immune Receptor Signaling and IRF Family of Transcription Factors: Good Deeds and Misdeeds in Oncogenesis

Fig. 7.1 Classification of CLRs by intracellular signaling motifs. Representative CLRs are classified based on their intracellular signaling motifs: ITAM-containing receptors (such as Dectin-1, CLEC2, CLEC9A, and SIGN-R3), adaptor-recruiting receptors…

read more

Development of Immunotherapy for Hepatocellular Carcinoma

Dec 10, 2016 by in ONCOLOGY Comments Off on Development of Immunotherapy for Hepatocellular Carcinoma

Year Author No. of patients Setting for DCs Responses 2002 Ladhams et al. 2 GM-CSF/IL-4 DC + tumor 1/2 inhibition of tumor growth 2003 Iwashita et al. 10 GM-CSF/IL-4 DC + tumor lysate + TNF-α + KLH 1/10…

read more

Quality of Care, Including Survivorship Care Plans

Dec 10, 2016 by in ONCOLOGY Comments Off on Quality of Care, Including Survivorship Care Plans

Fig. 17.1 Conceptual framework for receipt of optimal cancer care (Adapted from Shavers and Brown, JNCI 2002 with permission) After the initial treatment decisions are made, and treatments are underway,…

read more

Living with Metastatic Breast Cancer

Dec 10, 2016 by in ONCOLOGY Comments Off on Living with Metastatic Breast Cancer

Physical and medical challenges  Managing physical symptoms and side effects (e.g., pain, fatigue)  Dealing with constant or changing treatment schedules  Accepting stable disease as a desirable outcome of treatment  Maintaining…

read more
Get Clinical Tree app for offline access